Post by Ascensia Diabetes Care

We're proud to share that we’re expanding the CONTOUR® portfolio! Today, Ascensia Diabetes Care announced the launch of CONTOUR®COMFORT pen needles in Germany, Austria, and Switzerland — supporting stability, control, and confidence in the everyday injection experience for people living with diabetes. Daily injections are a reality for many people with diabetes, and even small improvements in usability and comfort can make a meaningful difference over time. That’s what makes this launch important. CONTOUR COMFORT pen needles are designed to support ease of use in daily therapy. They combine advanced 5-bevel tip technology and ergonomic design to maximize comfort and stability during injections for people living with diabetes and by healthcare professionals.¹,² Today’s launch marks the beginning of a broader international roll-out planned over the next two years. References: Liu, Y., et al. Int J Biomed Eng, June 2024, Vol 47 No. 3 Heinemann L. et al. Journal of Diabetes Science and Technology 2023, Vol 17(2) 449–457